Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary HIV infection.

L Perrin1

  • 1Laboratory of Virology, Division of Infectious Diseases, Geneva University Hospital, Geneva, Switzerland. Luc.perrin@hcuge.ch

Antiviral Therapy
|July 19, 2005
PubMed
Summary
This summary is machine-generated.

Primary HIV infection (PHI) involves acute symptoms and high viral load, which predict disease progression. Treatment decisions balance early intervention benefits against long-term adherence and toxicity concerns.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The critique of an artificial intelligence tool in the assessment of peripheral facial paralysis].

Annales de chirurgie plastique et esthetique·2024
Same author

Proteolytic and mechanical remodeling of the extracellular matrix by invadopodia in cancer.

Physical biology·2022
Same author

In vitro characterization and clinical evaluation of skin hydration by two formulations mimicking the skin's natural components.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

SATB2-associated syndrome: characterization of skeletal features and of bone fragility in a prospective cohort of 19 patients.

Orphanet journal of rare diseases·2022
Same author

Comparative study of luminescence and chemiluminescence in hydrodynamic cavitating flows and quantitative determination of hydroxyl radicals production.

Ultrasonics sonochemistry·2020
Same author

Iodine-Transfer Polymerization (ITP) of Ethylene and Copolymerization with Vinyl Acetate.

Angewandte Chemie (International ed. in English)·2020
Same journal

Safety and efficacy of deltoid intramuscular long-acting cabotegravir and rilpivirine, a case series.

Antiviral therapy·2026
Same journal

Factors associated with immunological non-response in HIV patients receiving antiretroviral therapy in Southeast Asia: A systematic review.

Antiviral therapy·2026
Same journal

Epidemiology and clinical management of cytomegalovirus infection in transplant recipients in Central and Eastern Europe - a physician survey.

Antiviral therapy·2026
Same journal

It's about time: The association between abacavir and cardiovascular disease.

Antiviral therapy·2026
Same journal

Combination antiviral and anti-CMV immunoglobulin therapy for CMV infection: A case-control study.

Antiviral therapy·2026
Same journal

Harnessing SuperNatural database to identify VP35 inhibitors as anti-Ebola drug candidates: A multistage <i>In silico</i> study.

Antiviral therapy·2025
See all related articles

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Acute human immunodeficiency virus (HIV) infection, or primary HIV infection (PHI), often presents with symptoms resembling infectious mononucleosis.
  • This phase is characterized by a rapid increase in viral load (viremia) followed by a spontaneous decline to a set point within six months.

Purpose of the Study:

  • To evaluate the factors influencing the decision to initiate antiretroviral therapy during the primary HIV infection stage.
  • To weigh the advantages of early treatment against potential long-term challenges.

Main Methods:

  • Analysis of clinical presentation during acute HIV infection.
  • Assessment of viral load dynamics and set point determination.
  • Consideration of factors impacting treatment adherence and drug toxicity.

Related Experiment Videos

Main Results:

  • The severity of acute retroviral syndrome and the viral set point are significant predictors of HIV disease progression.
  • Arguments for early treatment include viral population homogeneity, immune system preservation, and prevention of transmission.

Conclusions:

  • Treatment decisions for PHI require careful consideration of potential long-term drug toxicities and patient adherence.
  • Patient commitment is a critical factor in the successful management of HIV infection, particularly regarding treatment adherence.